Robert Watson

Robert Watson has over 10 years of work experience in various roles. Robert began their career in 2014 as a Managing Director at Altaris Capital Partners, LLC. From 2015 to 2021, they held Board Member roles at CMP Pharma, Inc., CSafe Global, Chemical Computing Group, and ReBio Technologies Limited. In 2019, they took on a Director Board Of Directors role at DuPont Sustainable Solutions. In 2020, they added a Director Board Of Directors role at Essential Pharma, and in 2021 they added Director Board Of Directors roles at Aleva Neurotherapeutics SA and CORCYM. Robert also held a Managing Partner role at Gyrus Capital from 2018 to 2021.

Robert Watson attended Eton College from 1991 to 1996, where they obtained their high school diploma. Robert then attended the University of Oxford from 1996 to 2000, where they earned an MBiochem in Biochemistry. Robert continued their studies at the University of Oxford from 2000 to 2004, where they obtained their DPhil in Neurology.